Empagliflozin reduced neuronal mortality, infarct size, and cognitive impairment via HIF-1/VEGF signalling in a dose-dependent manner in a rat model of cerebral ischemia/reperfusion damage [42]. Here, VEGFA is linked to Cognitive impairment.